It remains to be clarified whether the lack of FtMt is the primary cause of a disorder and whether the modulation of its expression, which is useful as an inhibitor of neoplastic growth in stroke and in neurodegenerative disease, can also be considered a valid therapeutic approach in humans. This evidence concerns the gene FTMT and neurodegenerative disease.